Bioactive adrenomedullin for assessment of venous congestion in heart failure
Abstract Aims Bioactive adrenomedullin (bio‐ADM) is a vascular‐derived peptide hormone that has emerged as a promising biomarker for assessment of congestion in decompensated heart failure (HF). We aimed to evaluate diagnostic and prognostic performance of bio‐ADM for HF in comparison to amino‐termi...
Main Authors: | Anna Egerstedt, Tomasz Czuba, Kevin Bronton, Carl Lejonberg, Thoralph Ruge, Torgny Wessman, Göran Rådegran, Janin Schulte, Oliver Hartmann, Olle Melander, J. Gustav Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14018 |
Similar Items
-
Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
by: Koji Takagi, et al.
Published: (2021-09-01) -
Procalcitonin and Adrenomedullin in Infectious Diseases
by: Yoshimitsu Kiriyama, et al.
Published: (2023-02-01) -
A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker
by: Anna Solé-Ribalta, et al.
Published: (2022-08-01) -
Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
by: Abdulla Ahmed, et al.
Published: (2023-08-01) -
Increased plasma adrenomedullin in patients undergoing percutaneous transluminal coronary angioplasty
by: MK Erol
Published: (2001-01-01)